MYLAN P157 (Metformin Hydrochloride and Pioglitazone Hydrochloride 850 mg / 15 mg (base))
Pill with imprint MYLAN P157 is White, Elliptical / Oval and has been identified as Metformin Hydrochloride and Pioglitazone Hydrochloride 850 mg / 15 mg (base). It is supplied by Mylan Pharmaceuticals Inc..
Metformin/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metformin/pioglitazone 850 mg / 15 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN P157
Metformin Hydrochloride and Pioglitazone Hydrochloride
- Imprint
- MYLAN P157
- Strength
- 850 mg / 15 mg (base)
- Color
- White
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-1575
More about metformin / pioglitazone
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 6 Reviews
- Drug class: antidiabetic combinations
- FDA Alerts (3)
Consumer resources
- Patient Information
- Pioglitazone and metformin (Advanced Reading)
- Pioglitazone and Metformin Extended-Release Tablets
- Pioglitazone and Metformin Tablets
- Other brands
- ActoPlus Met, ActoPlus Met XR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.